Accelerating the Development of a Malaria Vaccine

The research collaboration project, “Transmission-blocking Vaccine of Malaria” has been accepted by the Global Health Innovative Technology Fund’s product development program. Hamamatsu Pharma Research continues to challenge this new therapeutic field through a collaboration with University of Florida.

https://www.ghitfund.org/newsroom/press/detail/197/